Company intelligence / Profile preview

KALGen Innolab

Jakarta, Jakarta Special Capital Region, Indonesiakalgeninnolab.co.id ↗

Ownership: Private
Development stage: Other

Overview

KALGen Innolab is a leading Indonesian clinical laboratory specializing in molecular diagnostics and genomic testing. It pioneered anatomical pathology labs focused on molecular oncology in Indonesia and has developed several innovative assays including NGS-based panels for cancer mutations and COVID‑19 testing. The lab is accredited to international standards and serves as a key reference lab with nationwide reach.

Therapeutic areas: Rare DiseasesInfectious DiseasesHematologyOncologyOther
Modalities: Diagnostic testGenomic assayNext Generation Sequencing (NGS)
Industry: Molecular Diagnostics

Partnerships

Health Science Research Institute/Hoken Kagaku Kenkyujo (Japan)Toyota Tsusho CorporationDNALab Malaysia

Beyond the preview

Go deeper on KALGen Innolab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KALGen Innolab.

Explore the full profile